L-Ornithine L-Aspartate in Tanzania: NEMLIT level, who can prescribe it and STG references
L-Ornithine L-Aspartate is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level S (zonal, special and national hospitals). It is not on the DukaDawa pharmacy network yet, so we show no brands or prices for it. The Standard Treatment Guidelines mention it in 1 section.
Last updated
New to DukadawaRx? Register as a prescriber. Licensed prescribers only; we verify your registration before you can prescribe.
Is L-Ornithine L-Aspartate available on the DukaDawa pharmacy network?
Not yet. L-Ornithine L-Aspartate is not in the DukaDawa network catalogue, so we have no brands, prices or stock for it.
Prescribers can still write it on a DukadawaRx prescription, and we show it here as soon as a network pharmacy lists it.
Is L-Ornithine L-Aspartate on the NEMLIT, and who can prescribe it?
Yes. L-Ornithine L-Aspartate is on Tanzania's National Essential Medicines List (NEMLIT, 7th edition, 2026) at level S (zonal, special and national hospitals). At level S it may be prescribed by specialists.
- Level
- S (zonal, special and national hospitals)
- Category
- Cathartics (Gastro-Intestinal Medicines)
- Listed forms
- Granules: 3 gm, 6 gm Injection: 5gm/10ml
- Page
- NEMLIT, p. 22
| Level | Facility | Who may prescribe |
|---|---|---|
| A | Dispensary | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer, Assistant Clinical Officer |
| B | Health centre | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer, Clinical Officer |
| C | Council or district hospital | Specialist, Medical Officer, Dental Officer, Assistant Medical Officer |
| D | Regional referral hospital | Specialist, Medical Officer, Dental Officer |
| S (listed) | Zonal, special and national hospitals | Specialist |
A medicine is listed from the lowest facility level where it should be available.
Where is L-Ornithine L-Aspartate in the Standard Treatment Guidelines?
The Standard Treatment Guidelines (7th edition, 2026) mention L-Ornithine L-Aspartate in 1 section, most often section 10.5.4.4 Disorders of The Liver and Biliary Tract > Portal Hypertension > Hepatic Encephalopathy (HE) (p. 256). See the STG for treatment details.
- 10.5.4.4 Disorders of The Liver and Biliary Tract > Portal Hypertension > Hepatic Encephalopathy (HE), p. 256
Sections that mention L-Ornithine L-Aspartate, most mentions first. Positions only: see the STG for treatment details.
Related medicines
Sources
- Standard Treatment Guidelines and National Essential Medicines List (STG/NEMLIT), 7th edition, 2026, Ministry of Health, United Republic of Tanzania
Page last updated
STG positions are section numbers and printed page numbers only.
This page supports licensed prescribers and pharmacists. It is not medical advice and does not replace the Standard Treatment Guidelines, the product information or professional judgement. Prices and stock change often: confirm with the pharmacy.